31 results
8-K
EX-99.1
ANEB
Anebulo Pharmaceuticals Inc
13 Feb 24
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024
4:15pm
a meaningfully constructive solution to healthcare providers and to their patients suffering with ACI and associated cannabis toxicities,” Cunningham … burden on the healthcare system.”
“We are pleased to report that the USAN Council has adopted selonabant as the generic name for ANEB-001
8-K
EX-99.1
ANEB
Anebulo Pharmaceuticals Inc
14 Nov 23
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024
4:19pm
on the healthcare system, especially for patients who present with concomitant neuropsychiatric symptoms. When you consider the deregulation of cannabis
PRE 14A
tbh4np rkwmfzyfb
19 Oct 23
Preliminary proxy
5:18pm
8-K
2rcf4o33hp1f72 ks
6 Oct 23
Departure of Directors or Certain Officers
4:10pm
8-K
mb2sctm mm
28 Sep 23
Departure of Directors or Certain Officers
6:17pm
8-K
EX-99.1
8qw0hytgu
10 Nov 22
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates
8:15am
DEFR14A
jwbpw1
25 Oct 22
Revised proxy
5:27pm
8-K
EX-99.2
axq3v
5 Jul 22
Regulation FD Disclosure
8:17am
8-K
EX-99.1
zpwo5i
11 May 22
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates
9:00am